TNIP1
Basic information
Region (hg38): 5:151029945-151093577
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TNIP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 30 | 35 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 30 | 4 | 3 |
Variants in TNIP1
This is a list of pathogenic ClinVar variants found in the TNIP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-151030721-G-T | not specified | Uncertain significance (Oct 12, 2021) | ||
5-151032353-C-A | not specified | Uncertain significance (Jun 14, 2023) | ||
5-151033630-G-C | not specified | Uncertain significance (Jan 30, 2024) | ||
5-151033634-G-A | not specified | Uncertain significance (Mar 15, 2024) | ||
5-151033641-C-T | Benign (Dec 31, 2019) | |||
5-151033676-G-A | not specified | Uncertain significance (Dec 14, 2021) | ||
5-151033689-G-C | not specified | Uncertain significance (Mar 29, 2024) | ||
5-151033729-G-A | Likely benign (Dec 31, 2019) | |||
5-151033780-T-C | not specified | Uncertain significance (Mar 01, 2023) | ||
5-151033786-C-T | not specified | Uncertain significance (Mar 07, 2024) | ||
5-151035658-C-T | not specified | Uncertain significance (Dec 20, 2023) | ||
5-151035670-C-T | not specified | Uncertain significance (Aug 22, 2023) | ||
5-151036824-T-C | not specified | Uncertain significance (Jan 20, 2023) | ||
5-151036890-G-A | not specified | Uncertain significance (Jan 27, 2022) | ||
5-151039107-C-T | not specified | Uncertain significance (Mar 02, 2023) | ||
5-151039141-G-C | not specified | Uncertain significance (Jan 03, 2022) | ||
5-151039190-C-A | not specified | Uncertain significance (Feb 23, 2023) | ||
5-151042577-T-C | not specified | Uncertain significance (May 20, 2024) | ||
5-151042596-G-C | not specified | Uncertain significance (Jun 24, 2022) | ||
5-151042607-C-T | not specified | Uncertain significance (Jul 13, 2022) | ||
5-151042667-G-A | not specified | Uncertain significance (Oct 06, 2023) | ||
5-151042924-C-T | not specified | Uncertain significance (Jan 17, 2024) | ||
5-151045913-G-A | not specified | Uncertain significance (Jun 07, 2023) | ||
5-151045920-C-T | not specified | Uncertain significance (Aug 02, 2021) | ||
5-151049846-T-G | not specified | Uncertain significance (Oct 04, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TNIP1 | protein_coding | protein_coding | ENST00000389378 | 17 | 63633 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.476 | 0.524 | 125735 | 0 | 12 | 125747 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.757 | 325 | 366 | 0.889 | 0.0000227 | 4116 |
Missense in Polyphen | 153 | 189.33 | 0.80813 | 2094 | ||
Synonymous | 0.454 | 135 | 142 | 0.952 | 0.00000821 | 1220 |
Loss of Function | 4.38 | 8 | 36.6 | 0.219 | 0.00000179 | 434 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000882 | 0.0000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Inhibits NF-kappa-B activation and TNF-induced NF-kappa- B-dependent gene expression by regulating A20/TNFAIP3-mediated deubiquitination of IKBKG; proposed to link A20/TNFAIP3 to ubiquitinated IKBKG. Involved in regulation of EGF-induced ERK1/ERK2 signaling pathway; blocks MAPK3/MAPK1 nuclear translocation and MAPK1-dependent transcription. Increases cell surface CD4(T4) antigen expression. Involved in the anti- inflammatory response of macrophages and positively regulates TLR- induced activation of CEBPB. Involved in the prevention of autoimmunity; this function implicates binding to polyubiquitin. Involved in leukocyte integrin activation during inflammation; this function is mediated by association with SELPLG and dependent on phosphorylation by SRC-family kinases. Interacts with HIV-1 matrix protein and is packaged into virions and overexpression can inhibit viral replication. May regulate matrix nuclear localization, both nuclear import of PIC (Preintegration complex) and export of GAG polyprotein and viral genomic RNA during virion production. In case of infection, promotes association of IKBKG with Shigella flexneri E3 ubiquitin-protein ligase ipah9.8 p which in turn promotes polyubiquitination of IKBKG leading to its proteasome-dependent degradation and thus is perturbing NF-kappa-B activation during bacterial infection. {ECO:0000269|PubMed:12220502, ECO:0000269|PubMed:16684768, ECO:0000269|PubMed:17016622, ECO:0000269|PubMed:17632516, ECO:0000269|PubMed:20010814}.;
- Pathway
- Rac1-Pak1-p38-MMP-2 pathway;Post-translational protein modification;Metabolism of proteins;EGFR1;Ovarian tumor domain proteases;Deubiquitination
(Consensus)
Recessive Scores
- pRec
- 0.158
Intolerance Scores
- loftool
- 0.534
- rvis_EVS
- 0.67
- rvis_percentile_EVS
- 84.68
Haploinsufficiency Scores
- pHI
- 0.137
- hipred
- Y
- hipred_score
- 0.736
- ghis
- 0.468
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.491
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tnip1
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype; digestive/alimentary phenotype; immune system phenotype; renal/urinary system phenotype; liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype;
Gene ontology
- Biological process
- MyD88-dependent toll-like receptor signaling pathway;translation;defense response;inflammatory response;leukocyte cell-cell adhesion;glycoprotein biosynthetic process;protein deubiquitination;negative regulation of I-kappaB kinase/NF-kappaB signaling;negative regulation of viral genome replication;positive regulation of transcription by RNA polymerase II;positive regulation of inflammatory response;negative regulation of ERK1 and ERK2 cascade;modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade;positive regulation of protein deubiquitination
- Cellular component
- nucleoplasm;cytosol
- Molecular function
- protein binding;identical protein binding;mitogen-activated protein kinase binding